This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Najjar, S. Articles by Marwan Abu Ayash Search for Related Content PubMed PubMed Citation Articles by Najjar, S. Articles by Marwan Abu Ayash, Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB DEXAMETHASONE HYDROCORTISONE METYRAPONE Medline Plus Health Information Diabetes Diabetes Type 1 Dwarfism Obesity Obesity in Children Social Bookmarking                         What's this?

The Mauriac Syndrome

Department of Pediatrics, School of Medicine, American University of Beirut, Beirut, Lebanon

Marwan Abu Ayash

Department of Pediatrics, School of Medicine, American University of Beirut, Beirut, Lebanon

A ten-year-old girl, treated for diabetes mellitus with single daily doses of short acting insulin preparations for three years, presented with short stature, truncal obesity, round facies, and hepato megaly : the Mauriac syndrome. She had elevated levels of plasma cortisol suggesting hyperadreno corticism secondary to the poor diabetic control. The urinary excretion of 17 hydroxycorticoids and 17 ketosteroids were normal, however. The hypothalamic-hypophyseal-adrenal cortex axis was functionally normal. She had a normal growth hormone response to the administration of arginine monochloride. On adequate control of the diabetes mellitus, all the manifestations disappeared.

Clinical Pediatrics, Vol. 13, No. 9, 723-725 (1974)
DOI: 10.1177/000992287401300904


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?